Loading clinical trials...
Loading clinical trials...
The Importance of Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine Before Renal Transplantation
Conditions
Interventions
LifePort® perfusion machine
Locations
2
France
Urology CHRU-TOURS
Tours, I&L, France
CHR-ORLEANS Service d'Urologie
Orléans, Loiret, France
Start Date
March 15, 2017
Primary Completion Date
September 15, 2019
Completion Date
January 14, 2020
Last Updated
December 23, 2025
NCT07294183
NCT06674031
NCT06706492
NCT05086003
NCT03478215
NCT03504241
Lead Sponsor
University Hospital, Tours
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions